297 related articles for article (PubMed ID: 15665280)
1. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
Adams J; Williams SV; Aveyard JS; Knowles MA
Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
[TBL] [Abstract][Full Text] [Related]
2. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
Takle LA; Knowles MA
Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
[TBL] [Abstract][Full Text] [Related]
4. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
5. High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma.
Williams SV; Platt FM; Hurst CD; Aveyard JS; Taylor CF; Pole JC; Garcia MJ; Knowles MA
Genes Chromosomes Cancer; 2010 Jul; 49(7):642-59. PubMed ID: 20461757
[TBL] [Abstract][Full Text] [Related]
6. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
Bell SM; Zuo J; Myers RM; Knowles MA
Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
[TBL] [Abstract][Full Text] [Related]
8. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
9. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
[TBL] [Abstract][Full Text] [Related]
10. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
[TBL] [Abstract][Full Text] [Related]
11. Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines.
Venter DJ; Ramus SJ; Hammet FM; de Silva M; Hutchins AM; Petrovic V; Price G; Armes JE
Cancer Genet Cytogenet; 2005 Jul; 160(2):134-40. PubMed ID: 15993269
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas.
Chuaqui RF; Sanz-Ortega J; Vocke C; Linehan WM; Sanz-Esponera J; Zhuang Z; Emmert-Buck MR; Merino MJ
Cancer Res; 1995 Nov; 55(21):4995-8. PubMed ID: 7585541
[TBL] [Abstract][Full Text] [Related]
13. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
14. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer.
Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA
Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452
[TBL] [Abstract][Full Text] [Related]
17. Chromosome translocations in breast cancer with breakpoints at 8p12.
Courtay-Cahen C; Morris JS; Edwards PA
Genomics; 2000 May; 66(1):15-25. PubMed ID: 10843800
[TBL] [Abstract][Full Text] [Related]
18. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
[TBL] [Abstract][Full Text] [Related]
19. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
20. Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer.
Baffa R; Santoro R; Bullrich F; Mandes B; Ishii H; Croce CM
Clin Cancer Res; 2000 Apr; 6(4):1372-7. PubMed ID: 10778965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
